ストックスクリーナーアプリを入手
1.85
5.71%
0.10
前日終値:
$1.75
開ける：
$1.83
24時間の取引高:
34,502
Relative Volume:
0.07
時価総額：
$3.24M
収益：
-
当期純損益:
$-15.42M
株価収益率:
-1.0054
EPS:
-1.84
ネットキャッシュフロー:
$-13.41M
1週間 パフォーマンス:
-26.29%
1か月 パフォーマンス:
-48.47%
6か月 パフォーマンス:
+386.84%
1年 パフォーマンス:
+77.03%
1日の値動き範囲:
$1.65
$1.86
1週間の範囲:
$1.65
$2.64
52週間の値動き範囲:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
名前
Indaptus Therapeutics Inc
セクター
電話
(646) 427-2727
住所
3 COLUMBUS CIRCLE, NEW YORK
INDP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
1.85 | 3.06M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Indaptus Therapeutics Inc (INDP) 最新ニュース
Volume spikes in Indaptus Therapeutics Inc. stock – what they meanEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Ranking Indaptus Therapeutics Inc. among high performing stocks via toolsTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Why Indaptus Therapeutics Inc. stock could see breakout soonPortfolio Return Report & Low Volatility Stock Recommendations - newser.com
Will Indaptus Therapeutics Inc. rebound enough to break evenJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com
How high can Indaptus Therapeutics Inc. stock go2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
What momentum indicators show for Indaptus Therapeutics Inc. stockMarket Sentiment Summary & Daily Profit Focused Screening - newser.com
Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Indaptus Therapeutics (INDP) Price Target Decreased by 60.00% to 10.20 - MSN
Indaptus Therapeutics 3Q Research and Development Expenses About $1.52M >INDP - 富途牛牛
Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit - The Manila Times
Why Is Indaptus Therapeutics, Inc. (INDP) Stock Down Today? - Meyka
Indaptus (Nasdaq: INDP) showcases Decoy20 to tackle donor cell variability - Stock Titan
Volatility clustering patterns for Indaptus Therapeutics Inc.Weekly Trade Analysis & Reliable Intraday Trade Alerts - newser.com
Does Indaptus Therapeutics Inc. fit your quant trading modelJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com
Why retail investors pile into Indaptus Therapeutics Inc. stockWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Can Indaptus Therapeutics Inc. stock double in next 5 yearsSwing Trade & Expert Curated Trade Setups - newser.com
Is Indaptus Therapeutics Inc. stock ready for a breakoutWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
Key resistance and support levels for Indaptus Therapeutics Inc.Weekly Profit Summary & Community Verified Watchlist Alerts - newser.com
Exit strategy if you’re trapped in Indaptus Therapeutics Inc.Weekly Volume Report & High Yield Equity Trading Tips - newser.com
Is Indaptus Therapeutics Inc. stock a defensive play in 2025Insider Buying & AI Forecasted Stock Moves - Fundação Cultural do Pará
Visual trend scoring systems applied to Indaptus Therapeutics Inc.July 2025 Summary & Precise Trade Entry Recommendations - newser.com
Indaptus Therapeutics Reports Q3 2025 Financial Results and Corporate Update - Quiver Quantitative
Indaptus Therapeutics Q3 profit beats estimates - MarketScreener
Indaptus Therapeutics Q3 2025 Financial Results and Corporate Update - TradingView
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Indaptus Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Indaptus Therapeutics, Inc. Quarterly Earnings Report | INDP SEC FilingForm 10-Q - Stock Titan
[8-K] Indaptus Therapeutics, Inc. Reports Material Event | INDP SEC FilingForm 8-K - Stock Titan
Indaptus (NASDAQ: INDP) completes Decoy20 safety lead-in; $5.8M cash, runway to Q1 2026 - Stock Titan
Indaptus Therapeutics Inc (INDP) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):